ASGR1 and hepatocellular carcinoma: No significant differences were observed between the ASGR1 positive (46/78; 58.9%) and the ASGR1 negative (32/78; 41.1%) phenotype (p = 0.33), being ASGR1 expression more prevalent in cirrhotic (17/24; 70.8%) than in HCC (29/54; 53.7%) patients.